|
nasdaq:mnta
|
16609
|
Apr 21st, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
77.00
|
Open
|
|
Apr 20th, 2024 11:47PM
|
Apr 20th, 2024 11:47PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 20th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
77.00
|
Open
|
|
Apr 19th, 2024 11:45PM
|
Apr 20th, 2024 05:19PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 19th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
76.00
|
Open
|
|
Apr 18th, 2024 11:52PM
|
Apr 18th, 2024 11:52PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 18th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
76.00
|
Open
|
|
Apr 18th, 2024 12:00AM
|
Apr 18th, 2024 06:40PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 17th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
77.00
|
Open
|
|
Apr 16th, 2024 11:42PM
|
Apr 17th, 2024 03:05PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 16th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
77.00
|
Open
|
|
Apr 15th, 2024 11:38PM
|
Apr 16th, 2024 11:21AM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 15th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
77.00
|
Open
|
|
Apr 14th, 2024 11:34PM
|
Apr 15th, 2024 05:03PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 14th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
78.00
|
Open
|
|
Apr 13th, 2024 11:22PM
|
Apr 13th, 2024 11:22PM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 13th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
78.00
|
Open
|
|
Apr 12th, 2024 11:14PM
|
Apr 13th, 2024 11:48AM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mnta
|
16609
|
Apr 12th, 2024 12:00AM
|
Momenta Pharmaceuticals
|
16K
|
78.00
|
Open
|
|
Apr 11th, 2024 11:19PM
|
Apr 12th, 2024 08:43AM
|
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has led to the development of a number of novel therapeutics for immune-mediated diseases with high unmet need.
|
Open
|
|
Open
|
301 Binney St
|
Cambridge
|
Massachusetts
|
US
|
02142
|
|
Momenta Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|